Volitionrx Ltd (VNRX)

Currency in USD
0.537
-0.094(-14.90%)
Closed·
0.560+0.023(+4.21%)
·
Advertisement
Trading near 52-week Low
VNRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.5300.630
52 wk Range
0.53015.100
Key Statistics
Prev. Close
0.631
Open
0.62
Day's Range
0.53-0.63
52 wk Range
0.53-15.1
Volume
942.93K
Average Volume (3m)
514.86K
1-Year Change
-95.8295%
Book Value / Share
-4.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VNRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.966
Upside
+3,059.40%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Volitionrx Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 16.966
(+3,059.40% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy4.00+644.88%-New Coverage18/06/2026
Benchmark
Hold---Maintain02/06/2026
Jones Trading
Buy24.00+4,369.27%3.00Maintain18/05/2026
D. Boral Capital
Hold---Downgrade20/04/2026
H.C. Wainwright
Buy1.00+86.22%1.50Maintain06/04/2026

Volitionrx Ltd Earnings Call Summary for Q2/2026

  • VolitionRX posted Q2 2026 loss of $0.85/share vs. est. $0.606; revenue $398,660 vs. est. $460,010; shares fell 0.89% to $0.625 after-hours.
  • Operating expenses dropped 32% YoY to $4.6M amid 27% headcount cut; revenue flat at $0.4M but H1 2026 revenue doubled YoY to $1.4M.
  • Company withdrew full-year 2026 guidance citing unpredictable quarterly results driven by project timing and large order volatility.
  • Management expects $5M milestone from feline cancer publication, French lung cancer reimbursement filing in Q3, and sepsis program launch Sept 2026.
  • Cash position improved to $2.8M from $1.1M via $5.3M in equity raises; InvestingPro rates financial health 'WEAK' with 0.33 current ratio.
Last Updated: 14/08/2026, 14:34
Read Full Transcript

Earnings

Latest Release
13/08/2026
EPS / Forecast
-0.85 / -0.61
Revenue / Forecast
398.66K / 460.01K
EPS Revisions
Last 90 days

Compare VNRX to Peers and Sector

Metrics to compare
VNRX
Peers
Sector
Relationship
P/E Ratio
−0.2x−23.5x−0.4x
PEG Ratio
−0.010.400.00
Price/Book
−0.2x1.4x2.6x
Price / LTM Sales
2.1x7.3x3.1x
Upside (Analyst Target)
-23.6%48.4%
Fair Value Upside
Unlock−5.3%6.5%Unlock

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
120.41K1.45%80.50K
Other Institutional Investors
2.94M35.24%1.96M
Public Companies & Retail Investors
5.27M63.31%3.53M
Total
8.33M100.00%5.57M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Lagoda Investment Management, L.P.9.69%807,450540
Cotterford Company Limited7.21%600,267401

People Also Watch

7.5400
AKTX
+7.56%
0.8113
ONCO
-8.06%
2.920
CDT
-6.11%
1.150
EZGO
-6.50%
1.14
GMEX
-3.39%

FAQ

What Is the Volitionrx Ltd (NYSE: VNRX) Share Price Today?

The Volitionrx Ltd stock price today is 0.537 USD.

What Stock Exchange Does Volitionrx Ltd (VNRX) Trade On?

Volitionrx Ltd is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Volitionrx Ltd?

The stock symbol (also called a 'ticker') for Volitionrx Ltd is "VNRX."

What Is the Current Volitionrx Ltd Market Capitalisation?

As of today, Volitionrx Ltd (NYSE: VNRX) market cap is 4.420M USD.

What Is Volitionrx Ltd's (VNRX) Earnings Per Share (TTM)?

The Volitionrx Ltd EPS is currently -4.201 (Trailing Twelve Months).

When Is the Next Volitionrx Ltd Earnings Date?

Volitionrx Ltd's next earnings report will be released on 12/11/2026.

Is VNRX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Volitionrx Ltd moving averages and other technical indicators, the daily buy/sell signal for VNRX stock is Strong Sell.

How Many Times Has Volitionrx Ltd Stock Split?

Volitionrx Ltd has split 1 times. (See the VNRX stock split history page for full effective split date and price information.)

What is the current trading status of Volitionrx Ltd (NYSE: VNRX)?

As of 14/08/2026, Volitionrx Ltd (VNRX) is trading at a share price of 0.537 USD, with a previous close of 0.631 USD. The stock has fluctuated within a day range of 0.530 USD to 0.630 USD, while its 52-week range spans from 0.530 USD to 15.100 USD.

What Is Volitionrx Ltd (VNRX) Price Target According to Analysts?

The average 12-month price target for Volitionrx Ltd is 16.966 USD, with a high estimate of 24 USD and a low estimate of 4 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +3,059.40% Upside potential.

What Is the VNRX Premarket Price?

VNRX's last pre-market stock price is 0.620 USD. The pre-market share volume is 22,550.000, and the stock has decreased by -0.011, or -1.740%.

What Is the VNRX After Hours Price?

VNRX's last after hours stock price is 0.560 USD, the stock has decreased by 0.023, or 4.210%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.